TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Psychopathological symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spouse pregnancy rate
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: total therapeutic effect rate
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: incidence of blood loss-related outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: strain experienced across the Dual Construct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bpCR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of anaesthesia used
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Qualification of anaesthesia providers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Availability of essential drugs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: lower extremity lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of participants experiencing at least one adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: external eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ambulatory activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FBG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in mean NPRS score for low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate for low back pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased risk of ARF
Endpoint domain: Adverse events/effects
Primary endpoint: intraoperative hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence on US/CT
Endpoint domain: Mortality/survival
Primary endpoint: 5y-iDFS
Endpoint domain: Mortality/survival
Primary endpoint: daily active TV watching at 2 years
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Confidence in doffing and donning PPE equipment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of vitamin D deficiency (VDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to delegate home visits
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percentage of home visits made by health care assistants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Access to Infectious Diseases consultation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: ACR50-CRP response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EV NLRP3 protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum hs-CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of transverse expansion cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of retainers (fitting, speech, oral hygiene, durability, comfort)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aesthetic appearance of retainers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean percentage of root coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of GDF15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of TNFR1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of FAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs of union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hardware complications
Endpoint domain: Adverse events/effects
Primary endpoint: upper limbs functional performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: movement duration during functional tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spontaneous use of affected arm during daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvements in health measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 quality of life improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: histological outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or HFH
Endpoint domain: Mortality/survival
Primary endpoint: Seropositivity rates 2 to 2.5 years after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stage of change progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h PPA rates at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety signal detection
Endpoint domain: Adverse events/effects
Primary endpoint: Participation rate in tumor boards
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average workload of radiologists
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: MDRS change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequacy of tissue perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depth of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPS investigations for suspected child maltreatment
Endpoint domain: Adverse events/effects
Primary endpoint: total child emergency medical care use
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Child morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative anterior chamber inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Symptomatic RT-associated esophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: ECS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Five-year overall-survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Median RVP (MRVP) CLD/IOPstim
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D VAS improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NCIQ improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Opiate- and cocaine-negative urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Living out of poverty
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Likelihood of enrollment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Symptom stabilization based on total NSC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COSEF task scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Altitude-related adverse health effects
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of telemedicine consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of systolic blood pressure decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Multiple Sclerosis Quality of Life‐54
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity for diagnosing clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value for diagnosing clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during outpatient hysteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: keratinized tissue width (KTW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum indole 3-propionic acid (IPA) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of primary endpoint events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of uncomfortable experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pre-dialysis systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-dialysis systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduced mean scores on the Beery VMI and its supplemental tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual lesions within 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence at follow-up colonoscopy in 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Median time required for resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Body Fat Percentage (BFP) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Classification accuracy of the combined model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive function challenges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital mortality associated with atherectomy procedures
Endpoint domain: Mortality/survival
Primary endpoint: IGF‐I SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment burden reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time to first IV-PCA attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annual moderate/severe exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete clearance of actinic keratosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with recurrent lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life measured by SF-12 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Leg fat-free mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric knee extensor strength decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial MyoPS rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resistance (R) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactance (Xc) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone remodeling and integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support for the second molar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: recurrence rate of intestinal stricture
Endpoint domain: Mortality/survival
Primary endpoint: severity of symptoms for RLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine efficacy against prevalent HPV16 or 18 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HPV16 or 18 antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GM N‐acetylaspartate‐to‐total‐creatine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: heart rate variability (HRV) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of nausea within 24 hours after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Frequencies of adverse hemodynamic events
Endpoint domain: Adverse events/effects
Primary endpoint: Median length of stay in the postanesthesia care unit (PACU)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Knowledge of self-management procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall injury rates
Endpoint domain: Adverse events/effects
Primary endpoint: Understanding of neurological prognostication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: needle-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIHSS score improvement at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Modified Rankin Scale score improvement at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of early neurologic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: economic value of extended-release naltrexone and buprenorphine-naloxone
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Plasma cobalamin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Elevated tHcy concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Connectivity reduction between medial frontal cortex and fusiform
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Performance in the task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Carotid revascularization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total time for airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for placement of the i-gel™
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Failure Hospitalization (HHF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major Adverse Cardiovascular Events (MACE) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delayed ANC presentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Diagnosis of dementia
Endpoint domain: Mortality/survival
Primary endpoint: Final ISQ values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day mRS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: OUP increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in the number of day and night urinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increase in Qmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in prostate volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: excellent intubating conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of bacteremia
Endpoint domain: Adverse events/effects
Primary endpoint: 1-h postoperative incidence of CRBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRBD severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of rescue medication
Endpoint domain: Adverse events/effects
Primary endpoint: Average number of SBM per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: satisfaction for physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: RHI after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: aerodigestive reflex response frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dose error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose-volume histogram (DVH) error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pass rates for GTVnd and CTV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative decrease in albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predicted albumin loss over 4 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue-related functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concentric reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory results according to modified McKay's criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NYHA heart failure functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional cerebral blood flow (CBF) changes during cluster headache attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in pain coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FMA arm score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life years (LY)
Endpoint domain: Mortality/survival
Primary endpoint: Quality-adjusted life years (QALY)
Endpoint domain: Mortality/survival
Primary endpoint: Confirmed autoimmune disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hip extension ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: prevalence of newly infected cases of SARS‐CoV‐2
Endpoint domain: Adverse events/effects
Primary endpoint: grade 1 acute skin toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: grade 1 subcutaneous tissue toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: bioavailability of LCP-Tac compared to PR-Tac
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative dose per day to achieve equivalent trough levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax of LCP-Tac compared to PR-Tac
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative detectable prostate specific antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive margin rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Negative sentiments towards antidepressant usage
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: POGO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TTBGV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: TTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean increase in confidence managing difficult cases
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quiz scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood to incorporate practice changes
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Likelihood to seek HCV treatment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Open communication with medical providers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Time spent in hyperglycemia > 250 mg/dl during daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum selenium concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of low vitamin B12 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physiological care needs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH (Disabilities of the Arm, Shoulder and Hand)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck total lateral bending range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (DCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes